Drug intelligence / Profile preview

fish oil triglyceride

Development stage
Approved
Lead developer
Fresenius Kabi
Administration
Oral, Intravenous
01

Overview

Fish oil triglyceride is a formulation of fish oil in which the omega-3 fatty acids—primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)—are present as natural triglyceride esters. It is used as a dietary supplement and as a component in parenteral nutrition, and certain prescription formulations are approved for treatment of severe hypertriglyceridemia (≥500 mg/dL). The mechanism of action involves reduction of serum triglyceride levels through several proposed routes: omega-3 fatty acids may influence lipid metabolism by shifting cellular metabolism toward increased fatty acid oxidation and reduced triglyceride synthesis, promoting apolipoprotein B degradation, accelerating clearance of very-low-density lipoprotein (VLDL) particles, and modulating inflammatory processes through the production of resolvins and protectins. Fish oil triglyceride is most often administered orally, though parenteral preparations exist for use when oral or enteral nutrition is not possible[1][7].

Brand names
Omegaven
Other names
fish oilfish oil containing omega-3 acidsfish oilsomega-3 fish oilomega3 fish oilomega 3 fish oil
02

Targets

SREBP-1 / SREBF1 (SREBP-1)PPARG (Peroxisome proliferator-activated receptor gamma)PPARA (Peroxisome proliferator-activated receptor alpha)DGAT1 (Diacylglycerol O-acyltransferase 1)

Beyond the preview

Go deeper on fish oil triglyceride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fish oil triglyceride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call